# Clinicohematological and molecular analysis of hemoglobin D syndrome and unknown variants in the hemoglobinopathy spectrum of Sindh, Pakistan

**Authors:** Sunila Tashfeen, Ikram Din Ujjan, Hina Shaikh, Muhammad Arif Sadiq, Feriha Fatima Khidri, Ali Raza Rajput, Ali Muhammad Waryah, Kamlesh Kumari, Kamlesh Kumari, Kamlesh Kumari, Kamlesh Kumari

PMC · DOI: 10.1371/journal.pone.0320354 · PLOS One · 2025-05-15

## TL;DR

This study analyzed hemoglobin disorders in Sindh, Pakistan, identifying HbD and rare variants to improve diagnosis and prevention.

## Contribution

The study reports the identification of four new hemoglobin variants and emphasizes the importance of molecular analysis in screening.

## Key findings

- HbD Punjab is the most common hemoglobin variant in Sindh, Pakistan.
- Molecular analysis revealed four new mutations, including rare β-thalassemia and Hb variants.
- HbD syndromes were the most prevalent among hemoglobin variants at 56.6%.

## Abstract

Hemoglobinopathies are prevalent monogenic disorders resulting from genetic abnormalities in globin genes, significantly impacting health. β-thalassemia is particularly common in Pakistan, but data on other hemoglobin variants remain limited. This study aimed to investigate HbD syndrome, identify unknown variants, and examine the clinicohematological and molecular profiles of hemoglobinopathies in Sindh, Pakistan.

A prospective cross-sectional study was conducted from January 2021 to January 2023 at Liaquat University of Medical and Health Sciences (LUMHS), Jamshoro, Pakistan. Blood samples were collected from across Sindh, Pakistan and analyzed for hemoglobinopathies using hematological tests (CBC, peripheral blood smear), cation exchange high-performance liquid chromatography (CE-HPLC) and molecular analysis to confirm HbD and identify rare variants. Data were analyzed using SPSS v. 27.

Out of 4783 chromatograms analyzed, 1563 (32.7%) were diagnosed with hemoglobinopathies. The most common conditions included β-thalassemia (81.4%), hemoglobin (Hb) variants (11.2%), and hereditary persistence of fetal hemoglobin (7.4%). HbD was found in 2.1% of cases, with HbD syndromes being the most prevalent among Hb variants (56.6%). Sickle cell disorders followed with a frequency of 32%, and HbQ, HbE, and HbC were less common. Molecular analysis confirmed the HbD Punjab variant and identified an additional four mutations, i.e., one rare β-thalassemia mutation and three Hb variants including Hb Hinsdale, Hb Renert and Hb Takasago.

Hb D Punjab is the most prevalent hemoglobin variant in Sindh, Pakistan, followed by HbS and HbQ. Molecular analysis is essential for accurate diagnosis and identifying rare variants. Integrating HbD detection into screening programmes and genetic counselling can help prevent hemoglobinopathies. (S1 Abstract Graphic).

## Linked entities

- **Diseases:** hereditary persistence of fetal hemoglobin (MONDO:0020989)

## Full-text entities

- **Genes:** HBE1 (hemoglobin subunit epsilon 1) [NCBI Gene 3046] {aka HBE}, KRT90P (keratin 90, pseudogene) [NCBI Gene 85340] {aka HBA, KRT124P, KRTHBP1}, HBA1 (hemoglobin subunit alpha 1) [NCBI Gene 3039] {aka ECYT7, HBA-T3, HBH, METHBA}, FCAR (Fc alpha receptor) [NCBI Gene 2204] {aka CD89, CTB-61M7.2, FcalphaR, FcalphaRI}, HBG1 (hemoglobin subunit gamma 1) [NCBI Gene 3047] {aka HBG-T2, HBGA, HBGR, HSGGL1, PRO2979}, HBA2 (hemoglobin subunit alpha 2) [NCBI Gene 3040] {aka ECYT7, HBA-T2, HBH}, KRT88P (keratin 88, pseudogene) [NCBI Gene 85348] {aka HBC, KRT122P, KRTHBP3}, HBD (hypophosphatemic bone disease) [NCBI Gene 100187828], HBB (hemoglobin subunit beta) [NCBI Gene 3043] {aka CD113t-C, ECYT6, beta-globin}, IGKV2D-30 (immunoglobulin kappa variable 2D-30) [NCBI Gene 28881] {aka A1, IGKV2D30}, GPHA2 (glycoprotein hormone subunit alpha 2) [NCBI Gene 170589] {aka A2, GPA2, ZSIG51}, HBQ1 (hemoglobin subunit theta 1) [NCBI Gene 3049] {aka HBQ}
- **Diseases:** ACADEMIC EDITOR (MESH:D007859), Dbeta thalassemia (MESH:D013789), Iron deficiency (MESH:D000090463), monogenic disorders (MESH:D009358), Sickle cell disorders (MESH:D000755), hypochromic microcytic anemia (MESH:C536357), nutritional deficiencies (MESH:D044342), anemia (MESH:D000740), iron deficiency anemia (MESH:D018798), splenomegaly (MESH:D013163), birth defects (MESH:D000014), megaloblastic anemia (MESH:D000749), HbQ syndrome (MESH:D013577), DD (MESH:C536170), hereditary persistence of fetal hemoglobin (OMIM:617101), Hemoglobinopathies (MESH:D006453), chronic hemolysis (MESH:D006461), anaemia (MESH:D000743), HPFH (MESH:D009386), HbDQ disease (MESH:D004194), beta-thalassaemia (MESH:D017086), pain (MESH:D010146), malaria (MESH:D008288), Hb (MESH:D006445), Genetic diseases (MESH:D030342), HbD syndrome (MESH:D014808), infections (MESH:D007239), HbD and Q syndromes (MESH:D011778), HbD thalassemia (MESH:D017085), folate deficiency (MESH:C562799)
- **Chemicals:** vitamin B12 (MESH:D014805), Leishman (-), EDTA (MESH:D004492), B12 (MESH:C034730), folate (MESH:D005492)
- **Species:** Homo sapiens (human, species) [taxon 9606], Meleagris gallopavo (common turkey, species) [taxon 9103]
- **Mutations:** histidine for aspartic acid at codon 64, Gly > Arg, p.Asn140Lys, Glu > Ala, 27dupG, Asp > His, c.365A > C, 397A > G, Ser > Tyr, c.67G > C, p.Lys106*, c.49G > C, Glu > Gln, Glu > Val, 60C > A, 364G > C, c.263C > A, 401T > C, c.193G > C, C677T, c.68A > T, ASN-->Lys, c.226G > C, 420T > G, c.399A>T, Thr-->Asn, c.(29C > A, c.223G > C, Val-->Ala

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12080823/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12080823/full.md

## References

44 references — full list in the complete paper: https://tomesphere.com/paper/PMC12080823/full.md

---
Source: https://tomesphere.com/paper/PMC12080823